This Article Full Text Full Text (PDF) All Versions of this Article: 51/5/1393    most recent HYPERTENSIONAHA.107.104463v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ward, N. C. Articles by Croft, K. D. Search for Related Content PubMed PubMed Citation Articles by Ward, N. C. Articles by Croft, K. D. Related Collections Other hypertension Clinical Studies Other Vascular biology

(Hypertension. 2008;51:1393.)
© 2008 American Heart Association, Inc.

Original Articles

A Single Nucleotide Polymorphism in the CYP4F2 but not CYP4A11 Gene Is Associated With Increased 20-HETE Excretion and Blood Pressure

Natalie C. Ward; I-Jung Tsai; Anne Barden; Frank M. van Bockxmeer; Ian B. Puddey; Jonathan M. Hodgson; Kevin D. Croft

From the Schools of Medicine and Pharmacology (N.C.W., I-J.T., A.B., I.B.P., J.M.H., K.D.C.) and Surgery and Pathology (F.M.v.B.), University of Western Australia, Perth, Australia.

Correspondence to Natalie C. Ward, University of Massachusetts Medical School, Biotech V, 2nd Floor, 381 Plantation St, Worcester, MA 01605. E-mail nward{at}meddent.uwa.edu.au

Arachidonic acid is a major fatty acid that can be metabolized by the cytochrome P450 enzyme to a number of bioactive eicosanoids. A major metabolite of this oxidation is 20-hydroxyeicosatetraenoic acid, which acts as a potent vasoconstrictor. However, in the kidney, its vasoconstrictor actions can be offset by its natriuretic properties. A guanine-to-adenine polymorphism in the CYP4F2 gene was associated with a reduction in 20-hydroxyeicosatetraenoic acid production in vitro. A thymidine-to-cytosine polymorphism in the CYP4A11 gene reduced catalytic activity by >50% in vitro and was associated with hypertension. The aim was to determine whether these 2 mutations are associated with urinary 20-hydroxyeicosatetraenoic acid excretion and blood pressure in humans. For the CYP4F2, 51% were homozygous for the G allele, 40% were carriers, and 9% were homozygous for the A allele. For CYP4A11, 72% were homozygous for the T allele, 25% were carriers, and 3% were homozygous for the C allele. The CYP4F2 GA/AA genotype was significantly associated with an increase in both 20-hydroxyeicosatetraenoic acid excretion and systolic blood pressure. The CYP4A11 CC/TC genotype was significantly associated with a reduction in 20-hydroxyeicosatetraenoic acid excretion but was not associated with blood pressure. We have demonstrated for the first time in humans that polymorphisms of the CYP4F2 and CYP4A11 genes have opposite effects on 20-hydroxyeicosatetraenoic acid excretion. The positive association between the CYP4F2 GA/AA genotype and both systolic blood pressure and 20-hydroxyeicosatetraenoic acid excretion strengthens a role for 20-hydroxyeicosatetraenoic acid in the modulation of blood pressure.

Key Words: cytochrome P450 • CYP4F2 V433M • CYP4A11 F434S • 20-HETE • blood pressure

This article has been cited by other articles:

				J. H.Y. Wu, J. M. Hodgson, M. W. Clarke, A. P. Indrawan, A. E. Barden, I. B. Puddey, and K. D. Croft Inhibition of 20-Hydroxyeicosatetraenoic Acid Synthesis Using Specific Plant Lignans: In Vitro and Human Studies Hypertension, November 1, 2009; 54(5): 1151 - 1158. [Abstract] [Full Text] [PDF]

				K. Inoue, K. Sodhi, N. Puri, K. H. Gotlinger, J. Cao, R. Rezzani, J. R. Falck, N. G. Abraham, and M. Laniado-Schwartzman Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE Am J Physiol Renal Physiol, October 1, 2009; 297(4): F875 - F884. [Abstract] [Full Text] [PDF]

				V. Perez-Andreu, V. Roldan, A. I. Anton, N. Garcia-Barbera, J. Corral, V. Vicente, and R. Gonzalez-Conejero Pharmacogenetic relevance of CYP4F2 V433M polymorphism on acenocoumarol therapy Blood, May 14, 2009; 113(20): 4977 - 4979. [Abstract] [Full Text] [PDF]

				D. W. Nebert and C. L. Karp Endogenous Functions of the Aryl Hydrocarbon Receptor (AHR): Intersection of Cytochrome P450 1 (CYP1)-metabolized Eicosanoids and AHR Biology J. Biol. Chem., December 26, 2008; 283(52): 36061 - 36065. [Full Text] [PDF]

				C. Fava, M. Montagnana, P. Almgren, L. Rosberg, G. Lippi, B. Hedblad, G. Engstrom, G. Berglund, P. Minuz, and O. Melander The V433M Variant of the CYP4F2 Is Associated With Ischemic Stroke in Male Swedes Beyond Its Effect on Blood Pressure Hypertension, August 1, 2008; 52(2): 373 - 380. [Abstract] [Full Text] [PDF]